stars 1 stars 2 stars 3

SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. The group generates a revenue of 1.1 MM€ and operates 16 manufacturing plants and 9 R&D centers in Europe, North America and Asia. 3,300 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers. SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.

View Top Employees from SEQENS
Employees 1,275 (1,132 on RocketReach)
Founded 2003
Address 21, Chemin de la Sauvegarde, Écully, Auvergne-Rhône-Alpes 69130, FR
Industry Pharmaceutical Manufacturing, Pharmaceuticals, Pharmaceutical Synthesis, Distributors/Wholesale, Specialty Ingredients, Cosmetics, Research & Developement, CDMO, Custom Specialties, Mineral Specialties
Keywords Pharmaceutical Solutions, Pharmaceutical Intermediates, Specialty Ingredients, Active Ingredients, Drug Development And Manufacturing, Chemical, Biotechnology, Pharmaceuticals, Fine Chemical Manufacturing, Custom Synthesis

SEQENS Questions

Laurent Castor is the Vice-President Specialty Ingredients of SEQENS.

1,132 people are employed at SEQENS.

SEQENS is based in Écully, Auvergne-Rhône-Alpes.

Top SEQENS Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
G2Crowd Trusted
300K+ Plugin Users